Long COVID and Reduced Thrombosis in Antihistamine-Treated Patients: An Observational Study in the Metropolitan Area of Barcelona
Results suggest a protective effect of antihistamines against thrombotic events. While confirmation via multicenter, randomized trials is needed, a pragmatic approach using antihistamines could be considered for symptomatic patients in the early stage of infection.
Authors
- Celia Lozano-Paz (ORCID: https://orcid.org/0000-0003-2301-2509)
- Roger Valls-Foix (ORCID: https://orcid.org/0000-0002-1016-4039)
- María Llistosella (ORCID: https://orcid.org/0000-0003-0689-9005)
- Marta Gragea-Nocete
- Antonio Arévalo-Genicio
- Cristina Pérez-Díaz
- Ramon Roca-Puig
- Ma Carmen García-Arqué
- Vanessa Moro-Casasola
- Anna Puigdellívol-Sánchez
Institutions
- Hospital Terrassa (ES)
- Consorci Sanitari de Terrassa (ES)
- Madrid Health Service (ES)
- Mútua Terrassa (ES)
- Primary Health Care (QA)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Viruses
- Published
- 2026-02-02
- DOI
- https://doi.org/10.3390/v18020197
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00